U.S. Cath Labs Market Growth & Trends

The U.S. cath labs market size is expected to reach USD 24.3 billion by 2027, expanding at a CAGR of 5.3%, according to a new report by Grand View Research, Inc. The growing prevalence of cardiovascular diseases, the increasing number of coronary angiography performed each year, and the aging population prone to various heart problems, are the major factors driving the market. In addition, technological advancements and a growing preference for robot-assisted minimally invasive surgeries are other key factors propelling the growth of the market.

According to the American Heart Association (AHA), coronary artery disease affects 16.5 million Americans. The elective Percutaneous Coronary Intervention (PCI) is a commonly performed procedure in the U.S, with around 600,000 procedures performed each year. These procedures have the highest aggregate costs of all cardiovascular procedures, and PCI also has the third-highest aggregate cost of any surgical procedure, estimated at about USD 10.0 billion annually.

U.S. Cath Labs Market Report Highlights

  • The services segment dominated the market in 2019, attributed to a large number of patients seeking advanced diagnostic and treatment options for various heart diseases
  • With the technological advancements, and integration and technology collaboration between the cath laboratory and the equipment providers, the equipment segment is expected to witness significant growth during the forecast period
  • The therapeutics segment dominated the market in 2019, owing to increased patient preference for cath laboratory interventions, shorter hospital stays, smaller incisions at the site of surgery that reduces the risk of infection, less blood loss and transfusions, and other benefits
  • Stent placement dominated the therapeutic services segment in 2019 attributed to the growing annual incidence of Percutaneous Coronary Interventions (PCI) in the U.S.
  • Cardiac catheterization dominated the diagnostic segment attributed to the rising incidence of arterial blockage cases due to an unhealthy lifestyle in the region
  • Hospitals based cath laboratories have a major share owing to the patient flow and the increasing chronic and emergency case-patients. Moreover, better reimbursement available for the interventions performed at the hospitals is also driving the segment growth. Hospitals are revamping their existing cath labs and funding hybrid laboratories integration for treating multiple conditions under the same roof and for increased profitability
  • Mergers and acquisitions and technology collaborations are the main strategies followed by market leaders.